Crohn's disease patients treated with adalimumab benefit from co-treatment with immunomodulators

Translated title of the contribution: Crohn's disease patients treated with adalimumab benefit from co-treatment with immunomodulators

Research output: Contribution to journal › Article › Academic › peer-review

Translated title of the contribution	Crohn's disease patients treated with adalimumab benefit from co-treatment with immunomodulators
Original language	Undefined/Unknown
Pages (from-to)	324-325
Number of pages	2
Journal	Gut
Volume	61
Publication status	Published - 2012

Cite this

@article{bf504b0310694d64b716fd07ef851123,

title = "Crohn's disease patients treated with adalimumab benefit from co-treatment with immunomodulators",

author = "\{van der Valk\}, M.E. and \{van Oijen\}, M.G.H. and M. Ammerlaan and P.D. Siersema and B. Oldenburg",

year = "2012",

language = "Undefined/Unknown",

volume = "61",

pages = "324--325",

journal = "Gut",

issn = "0017-5749",

publisher = "BMJ Publishing Group",

}